OBJECTIVE
This study was undertaken to assess whether individual clinical factors or combinations thereof could be used to accurately predict the risk of delivery within 1 week of admission among women with preterm labor and minimal cervical dilatation.
STUDY DESIGN
We performed a case-control study of patients admitted to our institution with preterm labor and minimal cervical dilatation. A case patient was a patient who sought treatment with uterine contractions between 24 and 34 weeks' gestation with cervical dilatation </=2 cm, who received tocolysis with magnesium sulfate, and who was delivered within 7 days of admission. Control subjects were those who had the same presentation with preterm labor but were not delivered within the first 7 days after admission. The medical records of case patients and control subjects were then abstracted, and information on >70 potential predictors was recorded. Statistical analysis consisted of bivariate and multivariable methods. We also generated a multivariable clinical predictive model with the purpose of detecting a proportion as high as possible of those destined to be delivered within 1 week (high sensitivity). We estimated that we would need 50 case patients and 150 control subjects to detect an odds ratio of 2.5 for risk factors with a prevalence of 20%, an alpha error of.05, a beta error of.20, and a control subject/case patient ratio of 3:1.
RESULTS
Three variables were eligible for inclusion in our logistic models according to the bivariate analyses-bleeding on admission, substance abuse, and admission white blood cell count >/=14,000 cells/microL. The simplest and most favorable model included only 2 variables, bleeding and substance abuse, and yielded a sensitivity of 46% and a specificity of 76%. The full 3-variable model had similar test characteristics. For no model were we able to achieve a sensitivity >/=50%.
CONCLUSION
The results of this case-control study suggest that combinations of clinical factors do not yield an adequate level of discrimination to be used alone for predicting the likelihood of delivery within 1 week among patients with minimal degrees of cervical dilatation.
[1]
Treatment of preterm labor with the beta-adrenergic agonist ritodrine.
,
1992
.
[2]
R. H. Holbrook,et al.
Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial.
,
1997,
American journal of obstetrics and gynecology.
[3]
J. Ernest,et al.
Fetal fibronectin, interleukin-6, and C-reactive protein are useful in establishing prognostic subcategories of idiopathic preterm labor.
,
1995,
American journal of obstetrics and gynecology.
[4]
M. Morgan,et al.
Evidence for magnesium sulfate as a tocolytic agent.
,
1997,
Obstetrical & gynecological survey.
[5]
Daniel B. Mark,et al.
TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS
,
1996
.
[6]
I. Chalmers,et al.
Beta‐mimetics in preterm labour: an overview of the randomized controlled trials
,
1988,
British journal of obstetrics and gynaecology.
[7]
D. Hosmer,et al.
Applied Logistic Regression
,
1991
.
[8]
E. Saling,et al.
Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth-weight infants.
,
1996,
American journal of obstetrics and gynecology.
[9]
G. Lockitch,et al.
Fetal fibronectin improves the accuracy of diagnosis of preterm labor.
,
1995,
American journal of obstetrics and gynecology.
[10]
C. Wells,et al.
A comparison of multivariable mathematical methods for predicting survival--II. Statistical selection of prognostic variables.
,
1990,
Journal of clinical epidemiology.
[11]
S F Bottoms,et al.
The preterm prediction study: a clinical risk assessment system.
,
1996,
American journal of obstetrics and gynecology.